Keith Boulware

Keith Boulware serves as a Junior Contract Analyst within the Defense Health Agency (HT9406), supporting the acquisition of critical pharmaceutical and medical supply chain solutions essential to operational readiness. In this role, he assists in the full lifecycle management of procurement actions, from requirement validation and market research to contract documentation and compliance oversight. His work directly supports DHA’s mission to ensure seamless access to FDA-approved medications and advanced healthcare technologies for active-duty personnel, retirees, and their families. Boulware primarily handles acquisitions under the pharmaceutical preparation manufacturing NAICS code, focusing on sterile injectables, bulk active pharmaceutical ingredients, and specialized drug formulations required for military medical operations. Boulware maintains consistent working relationships with a core group of contractors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a focus on pharmaceutical manufacturing, medical device support, and secure logistics services critical to maintaining the integrity of the military’s pharmaceutical supply chain. His engagement with these vendors is characterized by structured, compliance-driven interactions aligned with federal acquisition regulations and DHA’s quality assurance protocols. Boulware’s procurement activities show no reliance on socioeconomic set-asides, with 100% of his assigned acquisitions conducted under full and open competition. This reflects a strategic emphasis on maximizing market access and ensuring rapid, scalable procurement of mission-critical pharmaceuticals without restriction, consistent with DHA’s operational urgency and national defense requirements. His technical expertise centers on NAICS 325412—Pharmaceutical Preparation Manufacturing—where he supports the acquisition of sterile, injectable, and specialty drug products used in combat support, expeditionary medicine, and chronic care programs. His domain knowledge includes GMP compliance, cold chain logistics, and drug stability requirements, positioning him as a key contributor to DHA’s efforts in modernizing its pharmaceutical procurement infrastructure.